Clinical Trials in Chicago

Showing 13141-13160 of 17,609 trials

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT00004095

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining irinotecan and gemcitabine in treating patients who have unresectable or metastatic solid tumors.

Bladder CancerBreast CancerColorectal Cancer+3 more

Northwestern University38 participantsStarted Aug 1999

Chicago, Illinois, United States

COMPLETEDNA2.2 miles

Effect of Nutritional Products in Subjects With Type 2 Diabetes

NCT02923960

This is a randomized, double blinded, multi treatment, crossover study intended to compare the glycemic and insulinemic response after consuming liquid nutritional products in people with type 2 diabetes.

Diabetes

Abbott Nutrition43 participantsStarted Oct 2016

Chicago, Illinois, United States • Cincinnati, Ohio, United States

COMPLETED2.2 miles

Salivary Diagnostic Testing for IVF

NCT02040545

This study aims to determine the performance of a salivary hormone competitive immunoassay for monitoring patients during treatment for infertility.

Infertility

Boston IVF335 participantsStarted May 2010

Pasadena, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Effect of Nutritional Products in Subjects With Type 2 Diabetes

Salivary Diagnostic Testing for IVF

Find Trials by Condition in Chicago

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

EXTEND (Eltrombopag Extended Dosing Study)

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study